Drug Testing Locations - Cape May, NJ

Drug Testing in Cape May, NJ

Cape May, New Jersey Statistics

In Cape May, Cape May County, drug overdose deaths increased by 25% in 2022 compared to the previous year.

Cape May City, Cape May County, reported a 15% rise in opioid-related arrests in 2021.

In 2022, Cape May County reported 300 cases of drug-related emergencies.

Cape May's population experienced a 20% increase in opioid addiction treatment admissions in 2021.

The city of Cape May, Cape May County, recorded 150 heroin possession cases in 2021.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Cape May, NJ & Drug Testing Policies

Employers in Cape May, NJ, take drug testing seriously as part of their workplace policies. Many businesses adhere to the guidelines provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) to maintain a safe and drug-free work environment. These policies help in reducing workplace accidents and ensuring employees are fit for duty.

Drug testing in Cape May workplaces can include pre-employment screening, random testing, and testing upon reasonable suspicion. Employers also offer access to employee assistance programs, helping their workers seek treatment if necessary, promoting recovery and reducing absenteeism.

Government Efforts with Drug Problems in Cape May, NJ

The government of Cape May, supported by Cape May County, has implemented various initiatives to combat drug issues. They collaborate with the New Jersey Department of Health and local agencies to provide resources and education on substance abuse. These efforts include public awareness campaigns and increased access to treatment services.

Additionally, Cape May city officials work closely with law enforcement to curb the distribution of illegal substances. The involvement of organizations like the Office of the New Jersey Coordinator of Addiction Responses and Enforcement Strategies ensures a coordinated approach to addressing drug-related problems.

Local Drug Busts & News in Cape May, NJ

Cape May has witnessed several significant drug-related events, contributing to increased efforts by law enforcement. In early 2022, a major drug bust in Cape May County resulted in the seizure of substantial amounts of heroin and cocaine, highlighting the ongoing challenges in combating drug trafficking in the region.

These operations are part of a broader effort by local authorities to dismantle drug networks in Cape May. News of these events often leads to enhanced public support for law enforcement and underscores the importance of community involvement in reporting suspicious activities.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Cape May, NJ. Trusted by employers nationwide for accurate results and exceptional service.

New Jersey DOT/Non DOT Physicals

New Jersey Vision Tests

New Jersey Audiograms

New Jersey Respirator Fit Tests

New Jersey Lift Tests

New Jersey Background Checks

Clinical Testing Services

TB Testing in NJ

Diabetes Testing in NJ

Infectious Disease Testing in NJ

Sickle Cell Anemia Testing in NJ

Women/Men's Health Testing in NJ

Resources & Citations

Partnership for a Drug-Free New Jersey

ASAP of Cape May County

Recovery Center of New Jersey

CAMcare Health Corporation

Narcotics Anonymous - New Jersey

NJ Division of Child Behavioral Health Services

Cape May County Health Department

Addictions Free America in New Jersey

Liberty Behavioral Health

New Hope Integrated Behavioral Health Care

Drug Testing Near Cape May, NJ

Cape May Point, NJ

West Cape May, NJ

Stone Harbor, NJ

North Cape May, NJ

Diamond Beach, NJ

North Wildwood, NJ

Wildwood Crest, NJ

Cape May Court House, NJ

Wildwood, NJ

West Wildwood, NJ

Villas, NJ

Erma, NJ

Burleigh, NJ

Whitesboro, NJ

Rio Grande, NJ

Frequently Asked Questions

Customer Reviews